Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
Nature Medicine2014Vol. 20(6), pp. 676–681
Citations Over TimeTop 10% of 2014 papers
Hong Qin, Beatrisa Lerman, Ippei Sakamaki, Guo‐Wei Wei, C Soungchul, Sheetal Rao, Jianfei Qian, Yared Hailemichael, Roza Nurieva, Karen C. Dwyer, Johannes Roth, Qing Yi, Willem W. Overwijk, Larry W. Kwak
Related Papers
- → Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells(2015)115 cited
- → Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma(2012)37 cited
- Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals.(1986)
- → Supplementary Figure 4 from COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells(2023)